CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Antiangiogenis vs. chemotherapy: Impact upon biomarkers in advanced hepatocellular cancer (HCC)
DOI 10.1055/s-2007-988176
Bibliografische Angaben
Nachweis in CareLit
Autor:innenG Treiber, T Wex, P Malfertheiner
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe09/2007
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: We have shown, that octreotide can effectively inhibit systemic VEGF-A secretion (J Cancer Res Clin Oncol 2006) in HCC patients. In a HCC mouse model, PDGF-B was associated with cell proliferation. This study was therefore designed to evaluate the impact of different Tx on established (s-Eselectin, VEGF-A) and new biomarkers (PDGF-BB) for angiogenesis. It was hypothesised that 1) conventional chemother…
Zitieren
Zitierempfehlung
G Treiber, T Wex, P Malfertheiner (2007) Antiangiogenis vs. chemotherapy: Impact upon biomarkers in advanced hepatocellular cancer (HCC). Zeitschrift für Gastroenterologie (09). https://doi.org/10.1055/s-2007-988176
Mit CareLit weiterarbeiten